Li Bao
Shenyang Pharmaceutical University(CN)Qiqihar University(CN)Capital Medical University(CN)Peking University(CN)Nankai University(CN)Beijing Jishuitan Hospital(CN)Beijing University of Technology(CN)Kunming Children's Hospital(CN)Zhuhai People's Hospital(CN)Advanced Energy Materials (United States)(US)Shenzhen Technology University(CN)China State Shipbuilding (China)(CN)Second Affiliated Hospital of Zhejiang University(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Cancer Treatment and Pharmacology
Most-Cited Works
- → MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial(2013)322 cited
- → Sunlight-driven simultaneous CO2 reduction and water oxidation using indium-organic framework heterostructures(2025)54 cited
- → CXCR4 is a good survival prognostic indicator in multiple myeloma patients(2013)39 cited
- → CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation(2013)35 cited
- → P144, A TGF-β1 Antagonist Peptide, Synergizes with Sildenafil and Enhances Erectile Response via Amelioration of Cavernosal Fibrosis in Diabetic Rats(2013)33 cited
- → Herlyn–Werner–Wunderlich syndrome: diverse presentations and diagnosis on MRI(2020)28 cited